SEC Form 4 · accession 0001213900-26-082326
Nano-X Imaging Ltd. · NNOX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Erez Meltzer
Officer — Chief Executive Officer · Director
Period of report
Jul 27, 2026
Accepted (ET)
Jul 28, 2026 · 4:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001795251
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 27, 2026 | P | 36,000 | $0.93 | A | 36,000 | I | By a wholly owned company |
| Ordinary SharesF2 | holding | — | — | — | 60,584 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy ordinary shares)F2,F3 | $2.21 | holding | — | — | — | — | Feb 11, 2030 | Ordinary Shares | 40,234 | 40,234 | D |
| Stock Option (right to buy ordinary shares)F2,F4 | $23.84 | holding | — | — | — | — | Jan 2, 2032 | Ordinary Shares | 300,000 | 300,000 | D |
| Stock Option (right to buy ordinary shares)F2,F5 | $11.52 | holding | — | — | — | — | Apr 16, 2034 | Ordinary Shares | 150,000 | 150,000 | D |
Explanation of responses
- F1The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
- F2There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
- F4The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
- F5The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).